Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...
Hosted on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
What if a single blood test could determine whether you had one of 14 types of cancer? That's the question posed by a study published in November in the journal Cancer. Conducted by researchers at the ...
The study, published in Nature Medicine, demonstrates that the Guardant360® test helps identify patients who may benefit from treatment and can identify alterations that predict resistance The study, ...
Here we conclude our discussion with David P. Carbone, MD, PhD, The Ohio State University, by addressing the importance of both advocacy for and education on biomarker testing in the lung cancer space ...
The promise of scientific and medical innovation often comes with a downside: improvements in care benefit some people, but not all. Without concerted effort, that is exactly what could happen with ...
CAMBRIDGE, Mass., March 3, 2026 /PRNewswire/ -- Droplet Biosciences, a diagnostics company pioneering lymph-based liquid biopsy testing, today announced that it is dramatically reducing genomic ...
Breast Cancer Liquid Biopsy Testing Devices Market · GlobeNewswire Inc. Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Breast Cancer Liquid Biopsy Testing Devices Market - Global Industry Size, Share, ...
DUBLIN--(BUSINESS WIRE)--The "Worldwide Market for Liquid Biopsy, 6th Edition" report has been added to ResearchAndMarkets.com's offering. Liquid biopsies have emerged as a minimally invasive ...
Ultra-sensitive liquid biopsy is expanding precision medicine access for patients in Japan with treatment-resistant non-small cell lung cancer (NSCLC) MENLO PARK, Calif., Jan. 6, 2026 /PRNewswire/ -- ...
During the 6 month period of the study, 1432 duodenal biopsies were received where celiac disease was part of the differential specified in the pathology request. Less than one-third of these patients ...
Barcelona-based testing service will advance cancer research and enable clinicians to personalize treatments more accurately and quickly for patients with late-stage cancer PALO ALTO, Calif. & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results